Parenteral Nutrition Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Parenteral Nutrition Market: By Type (Carbohydrates, Parenteral Lipid Emulsions, Amino Acid Solutions, Trace elements, Electrolytes, & Minerals Others), Dosage Form (Bags, Bottles, Others), Application (Adult, Pediatric) Disease (Cancer, Critical Care, Neurological Disorder, Gastrointestinal Diseases Others) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The parenteral nutrition market size is estimated to be valued at USD 2,437.2 million in 2021 and is `poised to grow at a significant CAGR of 7.4% over 2022-2028. Parenteral nutrition is a method of feeding liquid nutrients such as carbs, proteins, lipids, vitamins, minerals, electrolytes, vitamins, and proteins to persons who have a tube inserted into their stomach or small intestine. With more than 30.5% market share, the amino acid solution segment was the most popular. This is due to a rise in the use of amino acid solutions, which is linked to a rise in the number of regulatory-approved solutions. Amino acid solutions for parenteral nutrition are enriched in branched-chain amino acids and low in aromatic amino acids. amino acid solutions for parenteral nutrition provide the nine essential amino acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine) in amounts varying between 38 and 57% of total amino acids. Commonly used amino acid mixtures also provide nonessential amino acids comprising 43–62% of total amino acids which is essential for the body of the patent. Furthermore, freshly accessible amino acid solutions have fewer adverse effects, which improves patient outcomes. players are focusing on launching new products to maintain growth in the market for instance In 2018, Fresenius Kabi AG has launched mofKabiven extra Nitrogen, a three-chamber bag with a special protein-energy ratio, in Europe. The rising prevalence of malnutrition, chronic diseases, growing natality rate, and increasing premature births are among the primary factors catalyzing the demand for Parenteral Nutrition around the world.

Recent Market Developments:

In July, 2017, Baxter International, Inc., has acquired Claris Injectables Limited, which was a wholly-owned subsidiary of Claris Lifesciences Limited.

Parenteral Nutrition Market

MARKET SUMMARY
-
7.4%
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 7.4%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Parenteral Nutrition Market

  • The parenteral nutrition market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The parenteral nutrition market is segmented based on by nutrient type, consumer type, end-user, and geography.
Key Players
  • Braun Melsungen AG
  • Otsuka Pharmaceutical Factory Inc.
  • Baxter International Inc.
  • Allergan plc. (Actavis plc.)
  • Grifols S.A.,Pfizer Inc.
Parenteral Nutrition Market

Dynamics

The rising frequency of chronic diseases such as cancer is having a beneficial influence on product consumption throughout the world. Parenteral nutrition aids in the delivery of essential nutrients, which aids in the maintenance of strength, energy, and hydration in cancer patients at all stages from diagnosis to recovery. According to the World Health Organization, cancer causes roughly 8.2 million deaths per year, accounting for 13.0% of all deaths globally. Furthermore, new cancer cases are predicted to grow by 70.0 percent during the next two decades. the increasing prevalence of cancer is one of the key factors contributing to the market growth in the forecasting period.


North-America Got Significant Share

Parenteral Nutrition Market

North America accounted to recorded largest prominent share in parenteral nutrition market and the market is expected to grow at a significant growth rate over the forecast years owing to substantial research expenditures in the healthcare sector by commercial companies and government agencies, launch of newer products by the players, and cooperation between the medical device industry, regulatory bodies, universities, and others. Furthermore, the rising frequency of chronic conditions like cancer and malnutrition, as well as the existence of modern healthcare facilities and advantageous reimbursement policies and regulations in the region, have resulted in a high hospital admission rate, which has fueled strong product demand.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016-2021) and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Parenteral Nutrition Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content

1. Executive Summary
2. Global Parenteral Nutrition Market Introduction
2.1. Global Parenteral Nutrition Market – Taxonomy
2.2. Global Parenteral Nutrition Market –Definitions
2.2.1. By Type
2.2.2. By Dosage Form
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Parenteral Nutrition Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Parenteral Nutrition Market Dynamic Factors – Impact Analysis
3.6. Global Parenteral Nutrition Market – Competition Landscape
4. Global Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Parenteral Nutrition Market, By Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Carbohydrates
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Parenteral Lipid Emulsions
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Single Dose Amino Acid Solutions
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Trace elements, Electrolytes, & Minerals
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others (multivitamin Formulations)
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Global Parenteral Nutrition Market, By Dosage Form, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Bags
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Vials
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Ampules
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Bottles
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Global Parenteral Nutrition Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Premature Infants, Neonates and Children
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Geriatrics
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Chronic Disease Patients
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
8. Global Parenteral Nutrition Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Hospitals
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Clinics
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Homecare
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Others
8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
9. Global Parenteral Nutrition Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Region, 2022-2028
10. North America Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Carbohydrates
10.1.2. Parenteral Lipid Emulsions
10.1.3. Single Dose Amino Acid Solutions
10.1.4. Trace elements, Electrolytes, & Minerals
10.1.5. Others (multivitamin Formulations)
10.2. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Bags
10.2.2. Vials
10.2.3. Ampules
10.2.4. Bottles
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Premature Infants, Neonates and Children
10.3.2. Geriatrics
10.3.3. Chronic Disease Patients
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Homecare
10.4.4. Others
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Country, 2022-2028
10.7. North America Parenteral Nutrition Market Dynamics – Trends
11. Europe Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Carbohydrates
11.1.2. Parenteral Lipid Emulsions
11.1.3. Single Dose Amino Acid Solutions
11.1.4. Trace elements, Electrolytes, & Minerals
11.1.5. Others (multivitamin Formulations)
11.2. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Bags
11.2.2. Vials
11.2.3. Ampules
11.2.4. Bottles
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Premature Infants, Neonates and Children
11.3.2. Geriatrics
11.3.3. Chronic Disease Patients
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Homecare
11.4.4. Others
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Country, 2022-2028
11.7. Europe Parenteral Nutrition Market Dynamics – Trends
12. Asia-Pacific Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Carbohydrates
12.1.2. Parenteral Lipid Emulsions
12.1.3. Single Dose Amino Acid Solutions
12.1.4. Trace elements, Electrolytes, & Minerals
12.1.5. Others (multivitamin Formulations)
12.2. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Bags
12.2.2. Vials
12.2.3. Ampules
12.2.4. Bottles
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Premature Infants, Neonates and Children
12.3.2. Geriatrics
12.3.3. Chronic Disease Patients
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Homecare
12.4.4. Others
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Country, 2022-2028
12.7. Asia-Pacific Parenteral Nutrition Market Dynamics – Trends
13. Latin America Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Carbohydrates
13.1.2. Parenteral Lipid Emulsions
13.1.3. Single Dose Amino Acid Solutions
13.1.4. Trace elements, Electrolytes, & Minerals
13.1.5. Others (multivitamin Formulations)
13.2. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Bags
13.2.2. Vials
13.2.3. Ampules
13.2.4. Bottles
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Premature Infants, Neonates and Children
13.3.2. Geriatrics
13.3.3. Chronic Disease Patients
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Homecare
13.4.4. Others
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Country, 2022-2028
13.7. Latin America Parenteral Nutrition Market Dynamics – Trends
14. Middle East and Africa Parenteral Nutrition Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Carbohydrates
14.1.2. Parenteral Lipid Emulsions
14.1.3. Single Dose Amino Acid Solutions
14.1.4. Trace elements, Electrolytes, & Minerals
14.1.5. Others (multivitamin Formulations)
14.2. Dosage Form Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Bags
14.2.2. Vials
14.2.3. Ampules
14.2.4. Bottles
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Premature Infants, Neonates and Children
14.3.2. Geriatrics
14.3.3. Chronic Disease Patients
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Homecare
14.4.4. Others
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Parenteral Nutrition Market – Opportunity Analysis Index, By Type, Dosage Form, Application, End User, and Country, 2022-2028
14.7. MEA Parenteral Nutrition Market Dynamics – Trends
15. Competition Landscape 
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Actavis
15.2.2. B. Braun Melsungen
15.2.3. Baxter International
15.2.4. Fresenius Kabi
15.2.5. Grifols International
15.2.6. Hospira
15.2.7. Otsuka Pharmaceutical Factory
15.2.8. Sichuan Kelun Pharmaceutical
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Actavis
  • Braun Melsungen
  • Baxter International
  • Fresenius Kabi
  • Grifols International
  • Hospira
  • Otsuka Pharmaceutical Factory
  • Sichuan Kelun Pharmaceutical

Description

The parenteral nutrition market size is estimated to be valued at USD 2,437.2 million in 2021 and is `poised to grow at a significant CAGR of 7.4% over 2022-2028. Parenteral nutrition is a method of feeding liquid nutrients such as carbs, proteins, lipids, vitamins, minerals, electrolytes, vitamins, and proteins to persons who have a tube inserted into their stomach or small intestine. With more than 30.5% market share, the amino acid solution segment was the most popular. This is due to a rise in the use of amino acid solutions, which is linked to a rise in the number of regulatory-approved solutions. Amino acid solutions for parenteral nutrition are enriched in branched-chain amino acids and low in aromatic amino acids. amino acid solutions for parenteral nutrition provide the nine essential amino acids (histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine) in amounts varying between 38 and 57% of total amino acids. Commonly used amino acid mixtures also provide nonessential amino acids comprising 43–62% of total amino acids which is essential for the body of the patent. Furthermore, freshly accessible amino acid solutions have fewer adverse effects, which improves patient outcomes. players are focusing on launching new products to maintain growth in the market for instance In 2018, Fresenius Kabi AG has launched mofKabiven extra Nitrogen, a three-chamber bag with a special protein-energy ratio, in Europe. The rising prevalence of malnutrition, chronic diseases, growing natality rate, and increasing premature births are among the primary factors catalyzing the demand for Parenteral Nutrition around the world.

Recent Market Developments:

In July, 2017, Baxter International, Inc., has acquired Claris Injectables Limited, which was a wholly-owned subsidiary of Claris Lifesciences Limited.

Reviews

There are no reviews yet.

Be the first to review “Parenteral Nutrition Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX